HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy.

Abstract
Autosomal-dominant, Dutch-type cerebral amyloid angiopathy (D-CAA) offers a unique opportunity to develop biomarkers for pre-symptomatic cerebral amyloid angiopathy (CAA). We hypothesized that neuroimaging measures of white matter injury would be present and progressive in D-CAA prior to hemorrhagic lesions or symptomatic hemorrhage. In a longitudinal cohort of D-CAA carriers and non-carriers, we observed divergence of white matter injury measures between D-CAA carriers and non-carriers prior to the appearance of cerebral microbleeds and >14 years before the average age of first symptomatic hemorrhage. These results indicate that white matter disruption measures may be valuable cross-sectional and longitudinal biomarkers of D-CAA progression. ANN NEUROL 2022;92:358-363.
AuthorsZahra Shirzadi, Wai-Ying W Yau, Stephanie A Schultz, Aaron P Schultz, Matthew R Scott, Maged Goubran, Parisa Mojiri-Forooshani, Nelly Joseph-Mathurin, Kejal Kantarci, Greg Preboske, Marieke J H Wermer, Clifford Jack, Tammie Benzinger, Kevin Taddei, Hamid R Sohrabi, Reisa A Sperling, Keith A Johnson, Randall J Bateman, Ralph N Martins, Steven M Greenberg, Jasmeer P Chhatwal, DIAN Investigators
JournalAnnals of neurology (Ann Neurol) Vol. 92 Issue 3 Pg. 358-363 (09 2022) ISSN: 1531-8249 [Electronic] United States
PMID35670654 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2022 American Neurological Association.
Topics
  • Cerebral Amyloid Angiopathy (diagnostic imaging, pathology)
  • Cerebral Hemorrhage (diagnostic imaging, pathology)
  • Cross-Sectional Studies
  • Hemorrhage (pathology)
  • Humans
  • Magnetic Resonance Imaging
  • Neuroimaging
  • White Matter (diagnostic imaging, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: